Roche develops serology test to detect COVID-19 antibodies
April 17, 2020—Roche announced the development and upcoming launch of its Elecsys Anti-SARS-CoV-2 serology test to detect antibodies in people who have been exposed to the SARS-CoV-2 virus.
Webinars and Sponsored Roundtables — Register Now
Tuesday, April 28, 2026, 12:00 PM–1:00 PM ET
Discover how next-day comprehensive genomic profiling (CGP) is possible with the Oncomine Comprehensive Assay Plus on the Genexus System—delivering both speed and accuracy.
Webinar presenters Jane Bayani, MHSc, PhD, Assistant Professor and Co-Director, Diagnostic Development, Ontario Institute for Cancer Research, Canada, and Nicola Normanno, MD, Scientific Director, IRCCS Romagnolo Institute for the Study of Tumors, Italy, and Morten Grauslund, PhD, Molecular Biologist, Department of Pathology, Rigshospitalet/Copenhagen University Hospital, Copenhagen, Denmark.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Thermo Fisher Scientific. For Research Use Only. Not for use in diagnostic applications.
Thursday, April 30, 2026, 11:00 AM–12:00 PM ET
Hear an expert discuss how Memorial Sloan Kettering Cancer Center (MSKCC) is utilizing
the oncoReveal® Nexus 21-gene panel to redefine turnaround time and actionable insights
in cancer care. Dr. Ewalt shares a perceptive look at the clinical need for rapid, front-line NGS sequencing, and how a unique, purpose built targeted NGS panel (Pillar Biosciences’ oncoReveal Nexus 21 gene Panel) was developed, validated and implemented clinically by Memorial Sloan Kettering Cancer Center (MSK-REACT) to complement their current comprehensive genomic profiling (CGP) approach.
Webinar presenter Mark Ewalt, MD, Associate Medical Director for Laboratory Operations for Diagnostic Molecular Pathology in the Molecular Diagnostics Service, Department of Pathology and Laboratory Medicine, MSKCC.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Pillar Biosciences.
Thursday, May 28, 2026, 1:00–2:00 PM ET
This session is designed to improve understanding and application of recent updates to synoptic pathology reporting protocols such as the latest Reporting Template for Reporting Results of Biomarker Testing of Specimens from Patients with Carcinoma of the Breast. These changes reflect evolving clinical guidelines that directly influence diagnostic accuracy and treatment selection in breast cancer care.
Webinar presenters Thaer Khoury, MD, FCAP, Chair, Pathology and Laboratory Medicine, Roswell Park Comprehensive Cancer Cente, and Colin Murphy, CEO of mTuitive.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Subspecialties
Interactive Product Guides
Industry News
Qiagen launches Therascreen BRAF V600E kit
April 16, 2020—Qiagen launched its novel Therascreen BRAF V600E RGQ PCR Kit following FDA approval of the kit as a companion diagnostic to the BRAF inhibitor Braftovi (encorafenib).
Asuragen develops Armored RNA Quant SARS-CoV-2 control
April 16, 2020—Asuragen has developed an Armored RNA Quant SARS-CoV-2 Control for use in developing assays in response to the COVID-19 pandemic.
Stat Profile Prime Plus FDA cleared for POC use
April 15, 2020—Nova Biomedical announced the FDA has cleared its Stat Profile Prime Plus critical care blood gas analyzer for point-of-care use. This clearance allows POC personnel to perform bedside critical care testing with results in one minute.
Abbott launches third COVID-19 test
April 15, 2020—Abbott announced today the launch of its third COVID-19 test, a lab-based serology blood test for the detection of the IgG antibody that identifies if a person has had COVID-19.
BD gets second FDA EUA, CE mark for COVID-19 dx
April 13, 2020—BD announced that the FDA has granted emergency use authorization for a molecular diagnostic test for COVID-19 that can return results in two to three hours. The test also has been CE marked to the IVD directive.
OGT expands SureSeq NGS portfolio
April 13, 2020—Oxford Gene Technology has added detection capabilities for translocations and difficult-to-sequence partial tandem duplications in its MyPanel customizable SureSeq NGS panels.
Quansys Biosciences releases SARS-CoV-2 ELISA
April 10, 2020—Quansys Biosciences released its Q-Plex SARS-CoV-2 Human IgG (4-plex) enzyme-linked immunosorbent assay for the qualitative detection of SARS-CoV-2 reactive IgG class antibodies in human serum and plasma.
COVID-19 proficiency testing
April 10, 2020—The CAP has released a new proficiency testing program for the detection of SARS CoV-2 by nucleic acid amplification testing.
Aperio ImageScope DX Viewer approved for emergency use
April 9, 2020—Leica Biosystems has received notification from the FDA that its Aperio ImageScope DX Viewer with images acquired on the Aperio AT2 DX Scanner can be used for remote diagnosis under emergency use.